LPA is a chemorepellent for B16 melanoma cells: Action through the cAMP-elevating LPA 5 receptor

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Jongsma, Maikel ^a   Matas Rico, Elisa ^a   Rzadkowski, Adrian ^a   Jalink, Kees ^a   Moolenaar, Wouter H ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; AUTOTAXIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID 2 RECEPTOR; LYSOPHOSPHATIDIC ACID 5 RECEPTOR; LYSOPHOSPHATIDIC ACID 6 RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; RECEPTOR; RHO KINASE; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG; ALKYLGLYCEROPHOSPHOETHANOLAMINE PHOSPHODIESTERASE; DRUG DERIVATIVE; LYSOPHOSPHOLIPID; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3,4,5-TRIPHOSPHATE; PHOSPHODIESTERASE; POLYLYSINE; POLYPHOSPHOINOSITIDE; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

ARTICLE; CELL MEMBRANE; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; MELANOMA B16; MIGRATION INHIBITION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; ANIMAL; CELL FRACTIONATION; CELL POLARITY; CELL PROLIFERATION; CHEMOTAXIS; DRUG EFFECT; ENZYMOLOGY; EXPERIMENTAL MELANOMA; GENETIC TRANSFECTION; HELA CELL; HUMAN; METABOLISM; MOUSE; PATHOLOGY; SERUM;

ALPHA-MSH; ANIMALS; CELL MEMBRANE; CELL POLARITY; CELL PROLIFERATION; CHEMOTAXIS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HELA CELLS; HUMANS; LYSOPHOSPHOLIPIDS; MELANOMA, EXPERIMENTAL; MICE; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHORIC DIESTER HYDROLASES; POLYLYSINE; RECEPTORS, LYSOPHOSPHATIDIC ACID; SERUM; SPHINGOSINE; SUBCELLULAR FRACTIONS; TRANSFECTION;

EID: 83355173005     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029260     Document Type: Article

References (49)

1. Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, et al. (2010) LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol 50: 157-186.
2. Chun J, Hla T, Lynch KR, Spiegel S, Moolenaar WH, (2010) International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid Receptor Nomenclature. Pharmacol Rev 62: 579-587.
3. Eichholtz T, Jalink K, Fahrenfort I, Moolenaar WH, (1993) The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J 291 (Pt 3): 677-680.
4. van Meeteren LA, Moolenaar WH, (2007) Regulation and biological activities of the autotaxin-LPA axis. Prog Lipid Res 46: 145-160.
5. Aoki J, Inoue A, Okudaira S, (2008) Two pathways for lysophosphatidic acid production. Biochim Biophys Acta 1781: 513-518.
6. David M, Wannecq E, Descotes F, Jansen S, Deux B, et al. (2010) Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts. PLoS One 5: e9741.
7. Houben AJ, Moolenaar WH, (2011) Autotaxin and LPA receptor signaling in cancer. Cancer Metastasis Rev [Epub ahead of print].
8. Lin S, Wang D, Iyer S, Ghaleb AM, Shim H, et al. (2009) The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer. Gastroenterology 136: 1711-1720.
9. Liu S, Umezu-Goto M, Murph M, Lu Y, Liu W, et al. (2009) Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell 15: 539-550.
10. Nam SW, Clair T, Kim YS, McMarlin A, Schiffmann E, et al. (2001) Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res 61: 6938-6944.
11. Taghavi P, Verhoeven E, Jacobs JJ, Lambooij JP, Stortelers C, et al. (2008) In vitro genetic screen identifies a cooperative role for LPA signaling and c-Myc in cell transformation. Oncogene 27: 6806-6816.
12. van Leeuwen FN, Olivo C, Grivell S, Giepmans BN, Collard JG, et al. (2003) Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1. J Biol Chem 278: 400-406.
13. Stam JC, Michiels F, van der Kammen RA, Moolenaar WH, Collard JG, (1998) Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling. EMBO J 17: 4066-4074.
14. Kishi Y, Okudaira S, Tanaka M, Hama K, Shida D, et al. (2006) Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid. J Biol Chem 281: 17492-17500.
15. Hama K, Aoki J, Fukaya M, Kishi Y, Sakai T, et al. (2004) Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J Biol Chem 279: 17634-17639.
16. Gaetano CG, Samadi N, Tomsig JL, Macdonald TL, Lynch KR, et al. (2009) Inhibition of autotaxin production or activity blocks lysophosphatidylcholine-induced migration of human breast cancer and melanoma cells. Mol Carcinog 48: 801-809.
17. Chen M, Towers LN, O'Connor KL, (2007) LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells. Am J Physiol Cell Physiol 292: C1927-C1933.
18. Lee Z, Cheng CT, Zhang H, Subler MA, Wu J, et al. (2008) Role of LPA4/p2y9/GPR23 in negative regulation of cell motility. Mol Biol Cell 19: 5435-5445.
19. Evans JH, Falke JJ, (2007) Ca2+ influx is an essential component of the positive-feedback loop that maintains leading-edge structure and activity in macrophages. Proc Natl Acad Sci U S A 104: 16176-16181.
20. Wei C, Wang X, Chen M, Ouyang K, Song LS, et al. (2009) Calcium flickers steer cell migration. Nature 457: 901-905.
21. Lorenowicz MJ, Fernandez-Borja M, Hordijk PL, (2007) cAMP signaling in leukocyte transendothelial migration. Arterioscler Thromb Vasc Biol 27: 1014-1022.
22. Murray AJ, Tucker SJ, Shewan DA, (2009) cAMP-dependent axon guidance is distinctly regulated by Epac and protein kinase A. J Neurosci 29: 15434-15444.
23. Melnikova VO, Bolshakov SV, Walker C, Ananthaswamy HN, (2004) Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell lines. Oncogene 23: 2347-2356.
24. Yuan XB, Jin M, Xu X, Song YQ, Wu CP, et al. (2003) Signalling and crosstalk of Rho GTPases in mediating axon guidance. Nat Cell Biol 5: 38-45.
25. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, et al. (1998) Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396: 474-477.
26. Enserink JM, Christensen AE, de Rooij J, van Triest M, Schwede F, et al. (2002) A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol 4: 901-906.
27. Ponsioen B, Zhao J, Riedl J, Zwartkruis F, van der Krogt G, et al. (2004) Detecting cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator. EMBO Rep 5: 1176-1180.
28. Gray A, van der Kaay J, Downes CP, (1999) The pleckstrin homology domains of protein kinase B and GRP1 (general receptor for phosphoinositides-1) are sensitive and selective probes for the cellular detection of phosphatidylinositol 3,4-bisphosphate and/or phosphatidylinositol 3,4,5-trisphosphate in vivo. Biochem J 344 (Pt 3): 929-936.
29. Lemmon MA, (2007) Pleckstrin homology (PH) domains and phosphoinositides. Biochem Soc Symp 81-93.
30. Varnai P, Bondeva T, Tamas P, Toth B, Buday L, et al. (2005) Selective cellular effects of overexpressed pleckstrin-homology domains that recognize PtdIns(3,4,5)P3 suggest their interaction with protein binding partners. J Cell Sci 118: 4879-4888.
31. Fayard E, Xue G, Parcellier A, Bozulic L, Hemmings BA, (2010) Protein kinase B (PKB/Akt), a key mediator of the PI3K signaling pathway. Curr Top Microbiol Immunol 346: 31-56.
32. Khandoga AL, Pandey D, Welsch U, Brandl R, Siess W, (2011) GPR92/LPA lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaques. Cardiovasc Res 90: 157-164.
33. Williams JR, Khandoga AL, Goyal P, Fells JI, Perygin DH, et al. (2009) Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation. J Biol Chem 284: 17304-17319.
34. Kotarsky K, Boketoft A, Bristulf J, Nilsson NE, Norberg A, et al. (2006) Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes. J Pharmacol Exp Ther 318: 619-628.
35. Lee CW, Rivera R, Gardell S, Dubin AE, Chun J, (2006) GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5. J Biol Chem 281: 23589-23597.
36. Yin H, Chu A, Li W, Wang B, Shelton F, et al. (2009) Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. J Biol Chem 284: 12328-12338.
37. Williams JR, Khandoga AL, Goyal P, Fells JI, Perygin DH, et al. (2009) Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation. J Biol Chem 284: 17304-17319.
38. Kim A, Son M, Kim KI, Yang Y, Song EY, et al. (2009) Elevation of intracellular cyclic AMP inhibits NF-kappaB-mediated thymosin beta4 expression in melanoma cells. Exp Cell Res 315: 3325-3335.
39. Arikawa K, Takuwa N, Yamaguchi H, Sugimoto N, Kitayama J, et al. (2003) Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity. J Biol Chem 278: 32841-32851.
40. Wolff SC, Qi AD, Harden TK, Nicholas RA, (2005) Polarized expression of human P2Y receptors in epithelial cells from kidney, lung, and colon. Am J Physiol Cell Physiol 288: C624-C632.
41. Howe AK, (2004) Regulation of actin-based cell migration by cAMP/PKA. Biochim Biophys Acta 1692: 159-174.
42. Paulucci-Holthauzen AA, Vergara LA, Bellot LJ, Canton D, Scott JD, et al. (2009) Spatial distribution of protein kinase A activity during cell migration is mediated by A-kinase anchoring protein AKAP Lbc. J Biol Chem 284: 5956-5967.
43. Simpson KJ, Selfors LM, Bui J, Reynolds A, Leake D, et al. (2008) Identification of genes that regulate epithelial cell migration using an siRNA screening approach. Nat Cell Biol 10: 1027-1038.
44. Smolen GA, Zhang J, Zubrowski MJ, Edelman EJ, Luo B, et al. (2010) A genome-wide RNAi screen identifies multiple RSK-dependent regulators of cell migration. Genes Dev 24: 2654-2665.
45. Chen L, Zhang JJ, Huang XY, (2008) cAMP inhibits cell migration by interfering with Rac-induced lamellipodium formation. J Biol Chem 283: 13799-13805.
46. Howe AK, Baldor LC, Hogan BP, (2005) Spatial regulation of the cAMP-dependent protein kinase during chemotactic cell migration. Proc Natl Acad Sci U S A 102: 14320-14325.
47. Lim CJ, Kain KH, Tkachenko E, Goldfinger LE, Gutierrez E, et al. (2008) Integrin-mediated protein kinase A activation at the leading edge of migrating cells. Mol Biol Cell 19: 4930-4941.
48. Lundequist A, Boyce JA, (2011) LPA5 is abundantly expressed by human mast cells and important for lysophosphatidic acid induced MIP-1beta release. PLoS One 6: e18192.
49. Tabata K, Baba K, Shiraishi A, Ito M, Fujita N, (2007) The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor. Biochem Biophys Res Commun 363: 861-866.